Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: J Magn Reson Imaging. 2013 Mar;37(3):544–555. doi: 10.1002/jmri.23731

Fig 15.

Fig 15

Intravenous gadolinium contrast administration does not affect hepatic stiffness. MRE in a chronic hepatitis B patient with biopsy confirmed stage 3 fibrosis before (top row) and after (bottom row) administration of intravenous gadolinium agent shows no significant change in hepatic stiffness (3.6 and 3.7 kPa respectively).